.png){kind=small}
Teva will not be able to market a generic version of Zisapel’s drug
April 2021
The court has issued a temporary restraining order prohibiting the Israeli pharmaceutical giant from launching a generic version of the drug Sikardin, which treats sleep disorders, of the Neurim Pharmaceuticals Company controlled by Nava and Yehuda Zisapel.
Neurim Pharmaceuticals was represented by Adv. Gabriel (Gabi) Moyal-Maor and Eleanor Stark from our litigation department.
To read the full article in Hebrew click here.
